Abstract P4-14-01: Trastuzumab emtansine improves overall survival versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer: Final results from the phase 3 EMILIA study

2016 ◽  
Author(s):  
V Diéras ◽  
D Miles ◽  
S Verma ◽  
M Pegram ◽  
M Welslau ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Overall Survival ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Trastuzumab Emtansine ◽  
Her2 Positive ◽  
Phase 3 ◽  
Previously Treated

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial

2014 ◽  
Vol 15 (7) ◽  
pp. 689-699 ◽  
Author(s):  
Ian E Krop ◽  
Sung-Bae Kim ◽  
Antonio González-Martín ◽  
Patricia M LoRusso ◽  
Jean-Marc Ferrero ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Trastuzumab Emtansine ◽  
Her2 Positive ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase ◽  
Versus Treatment
Sign in / Sign up

Export Citation Format

Share Document